An experimental oral medicine, called vadadustat, could represent a new, more convenient and potentially safer way to treat anemia, a common condition for patients with chronic kidney disease.
An experimental oral medicine, called vadadustat, could represent a new, more convenient and potentially safer way to treat anemia, a common condition for patients with chronic kidney disease.
Copyright © 2023 Biotech Networks, LLC